hgen info.


https://ir.humanigen.com/English/news/news-details/2022/Humanigen-Implements-Strategic-Realignment-of-Pipeline-and-Resources-to-Achieve-Key-Clinical-Milestones/default.aspx

some posts on the



Y board how steroids affect male, female differently, also different doses,
regarding vtgn.

sometimes add turmeric


to food dishes,
supposed use in ancient times to help with arthritis.
or would that now be considered homeopathic.

https://en.wikipedia.org/wiki/Homeopathy.

also take one plaquenil, although my eye doc has said the less you take
of that, the better.

market caps at close.


hgen 33m.

rlftf 153m.

cydy 420m.

things don't go, the way we (i) think.

hgen.....fail


https://ir.humanigen.com/English/news/news-details/2022/Humanigen-Receives-Preliminary-Topline-Data-From-NIHNIAID-Study-of-Lenzilumab-in-ACTIV-5BET-B/default.aspx

b4-5 info.


https://www.msn.com/en-us/news/us/as-the-ba-5-variant-spreads-the-risk-of-coronavirus-reinfection-grows/ar-AAZpFDy?ocid=msedgntp&cvid=0906eff65e164966a810468d47a943b2

nih web site info. hgen.


https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/35793833

veru info.



https://finance.yahoo.com/news/veru-announces-england-journal-medicine-113000271.html

gene editing,


perhaps some interest here, no position.
always wonder, newton's law, gravity. for ever action, a equal and opposite action.
know it does not apply here, but when something changes, it seems that something
else does to.

hgen info.


https://ir.humanigen.com/English/news/news-details/2022/NIHNIAID-Locks-ACTIV-5BET-B-Database/default.aspx

new monkeypox cases.


https://www.msn.com/en-us/health/medical/2-monkeypox-cases-now-confirmed-in-minnesota/ar-AAYZK8l?ocid=msedgdhp&pc=U531&cvid=f43c2ea278b941bbbef22070f056c862

Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC
June 29, 2022 at 7:30 AM EDT



https://investors.galeratx.com/news-releases/news-release-details/galera-announces-results-phase-1-stage-greco-1-trial-rucosopasem

abortion pill has other use.



https://www.msn.com/en-us/news/us/the-abortion-pill-may-treat-dozens-of-diseases-but-roe-reversal-might-upend-research/ar-AAYR4h7?ocid=msedgdhp&pc=U531&cvid=5ed39aaa429b48c296fcb6bd70f9dd97

What Omicron’s BA.4 and BA.5 variants mean for the pandemic.


https://www.nature.com/articles/d41586-022-01730-y.


https://www.beckershospitalreview.com/public-health/ba-4-ba-5-sister-variants-escape-antibody-response-more-than-previous-strains.html.

promise, but quite a way's down the road.

https://www.onjcri.org.au/uncategorized/clinical-trial-lighting-up-hope-for-brain-cancer-patients/

I kind of caught


that, lol.

take it you see some
worth here.


https://www.enanta.com/pipeline/sars-cov-2/.

best.

b-4 b-5 info


https://www.yahoo.com/news/covid-reinfections-set-to-spike-in-us-as-new-variants-evade-immunity-220029351.html

monkeypox vax info.


https://www.msn.com/en-us/health/medical/monkeypox-vaccines-are-too-gnarly-for-the-masses/ar-AAYrV0T?ocid=msedgdhp&pc=U531&cvid=6dcbec713b2a4aadae51ec8d8d4ae253.


on a side note, preclinical bios, with early work, not much love.
tonix has book value of 12.00 and cash of 7.00.
suppose the thinking is revenue is down the road and they will burn through
the cash. likely pertains to most small bios without revenue. IMO.

used to think B/V and cash was close to the bottom. perhaps more so in
non biotech's.

hgen results this month, supposedly.


Clinicaltrials site for ACTIV5-BETB updated today and shows study completed April 22, 2022.

https://www.clinicaltrials.gov/ct2/show/NCT04583969.

sweat time.

b4-b5 info.


https://www.msn.com/en-us/health/medical/there-s-a-new-more-contagious-omicron-strain-and-it-s-in-miami-dade-here-s-what-we-know/ar-AAYeC3d?bk=1&bk=1&ocid=msedgdhp&pc=U531&cvid=d34774c71676491aaf6b070eadbaf5ca

share buy back, see what tomorrow brings.

https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-share-repurchase-200500869.html

lot of shorts in this one, perhaps.

https://finance.yahoo.com/quote/TNXP/community?p=TNXP

would agree with toxic,



with their use of shareholders and reverse splits, at least the amount they have
done. small position, see what happens, maybe they move if they p. r. something
on monkeypox.
nobles gave them a ten dollar price target if they prioritize TNX-801, a vaccine to prevent smallpox and monkeypox.

some weekend tonix history.

looks like they are trying to go big and using shareholders and RS's
to do it. last RS , 32-1 ,not much left after that one.
took a small position after the rs, and with their history, they likely,
at some point, will do another, hope to be out before that happens.

https://en.wikipedia.org/wiki/Tonix_Pharmaceuticals

https://finance.yahoo.com/quote/TNXP?p=TNXP

info. asco




https://investors.galeratx.com/news-releases/news-release-details/galera-announces-oral-presentation-2022-american-society

last hour or so



looks like someone has a buy in for everything up to and including 2.05

insider buys the last three days.
but he did sell the stock down to where it is now.
p-3 live air results, perhaps in a short time, could move stock price either way.
about a million shares in three days.

https://www.otcmarkets.com/filing/html?id=15837884&guid=MHKwkK7YUFn4B3h


https://s28.q4cdn.com/539885110/files/doc_presentations/2022/HGEN-Corporate-Deck-5-19-22.pdf

rucosopasem is in early testing,

dealing with pancreatic cancer, could be the real gem here, if successful. IMO.

https://www.bizjournals.com/philadelphia/news/2022/05/16/galera-therapeutics-malvern-nda-cancer-mucostitis.html?ana=yahoo

more info june 3 at asco.

rucosopasem is still in early testing.

but it deals with pancreatic cancer and could, if successful, be the
real gem. IMO.

more info at asco june 3.

https://www.bizjournals.com/philadelphia/news/2022/05/16/galera-therapeutics-malvern-nda-cancer-mucostitis.html?ana=yahoo

GRTX P. R.




https://investors.galeratx.com/news-releases/news-release-details/galera-reports-first-quarter-2022-financial-results-and-recent.


https://investors.galeratx.com/news-releases/news-release-details/galera-announces-plan-submit-avasopasem-nda-year-end.

PR info.



https://investors.galeratx.com/news-releases/news-release-details/galera-announces-plan-submit-avasopasem-nda-year-end.


https://investors.galeratx.com/news-releases/news-release-details/galera-reports-first-quarter-2022-financial-results-and-recent

grtx results p-2



https://investors.galeratx.com/news-releases/news-release-details/galera-announces-topline-results-phase-2a-aesop-trial-avasopasem

asco info.


https://investors.galeratx.com/news-releases/news-release-details/galera-present-2022-american-society-clinical-oncology-asco

sounds like some poster info

will be given at asco, on pancreatic trial, along with oral head and neck
cancer p-3 SOM.


https://investors.galeratx.com/news-releases/news-release-details/galera-present-2022-american-society-clinical-oncology-asco.

got a quick reply



from the company that it is real.

email them yourself, the reply was quick.

emailed the company.


if they reply, will post.

car-t info.



https://www.otcdynamics.com/hgen-gm-csf-knock-out-car-t-study-published-in-peer-reviewed-journal-leukemia/?utm_campaign=twitter&utm_medium=twitter&utm_source=twitter

car-t hgen info.


https://www.otcdynamics.com/hgen-gm-csf-knock-out-car-t-study-published-in-peer-reviewed-journal-leukemia/?utm_campaign=twitter&utm_medium=twitter&utm_source=twitter

info.



https://investors.galeratx.com/static-files/dcfc4907-65f7-4ca9-915c-d37eb17339ff


https://www.galeratx.com/

grtx results.




https://investors.galeratx.com/news-releases/news-release-details/galera-reports-fourth-quarter-and-full-year-2021-financial